The Munich-based Wacker Group is expanding collaboration with the Swiss market expansion services group DKSH in Southeast Asia. In addition to representing Wacker biotech products, DKSH will market pyrogenic silica and silicones for the cosmetic, food and pharmaceutical industries beginning in November.
Wacker transferred responsibility for marketing cyclodextrins, cystine and cysteine in Southeast Asia to DKSH in early October.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
Porelio's FOMS adsorbents target PFAS, metals, and genotoxins, outperforming commercial solutions with unmatched selectivity, innovation, and sustainability.
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
It is important to examine the current state of bio-based polymers. This includes the rapidly growing production capacity, significant investments currently underway in China, Europe, and the Middle East, and the new political conditions in Europe that are driving demand for biodegradable polymers.
